Skip to main content
. 2024 Mar 5;10(5):e27298. doi: 10.1016/j.heliyon.2024.e27298

Table 3.

Pharmacokinetic properties of compound 1 isolated from Pistacia chinensis.

SMILES = “COC1=C(OC2=C(C=CC(O)=C2O)C1=O)C1=CC=C(O)C(O)=C1”
Absorption
Properties Numeric with unit
01 Water solubility −3.424 log mol/L
02 Caco2 permeability −0.149 log Papp in 10−6 cm/s
03 Intestinal absorption (human) 86.156 %
04 Skin Permeability −2.735 log kp
05 P-glycoprotein (substrate) Yes
06 P-glycoprotein I (inhibitor) No
07 P-glycoprotein II (inhibitor) No
Distribution
01 BBB permeability −1.411 log bb
02 CNS permeability −3.499 log PS.
Biotransformation
01 CYP2D6 (substrate) No
02 CYP3A4 (substrate) No
03 CYP1A2 (inhibitor) Yes
Excretion
01 Total Clearance 0.449 log ml/min/kg
02 Renal OCT2 (substrate) No
Toxicity
01 AMES toxicity Yes
02 Max. Tolerated dose (human) 0.804 log mg/kg/day
03 Oral Rat Acute Toxicity (LD50) 2.546 mol/kg
04 Oral Rat Chronic Toxicity (LOAEL) 2.178 log mg/kg_bw/day
05 Hepatotoxicity No
06 Skin Sensitisation No
07 Tetrahymena pyriform toxicity 0.298 log ug/L
08 Minnow toxicity 1.354 log Mm
Physicochemical properties
01 Number of rotatable bonds 02
02 Number of H-bond (acceptors) 07
03 Number of H-bond (donors) 04
Druglikeness
01 Lipinski Yes (No violation)